Pre-earnings options volume in Sellas Life Sciences is normal with calls leading puts :. Implied volatility suggests the market is anticipating a move near 20.1%, or 0c, after results are released. Median move over the past eight quarters is 19.7%.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SLS:
- SELLAS Life Sciences Group Announces Closing of $20 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
- SELLAS Life Sciences to Host Corporate Update Call on March 26, 2024, at 8:15 am ET
- Is SLS a Buy, Before Earnings?
- Sellas prices 13.03M shares at $1.535 in direct offering, private placement
- SELLAS Life Sciences Group Announces $20 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
